Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics.

Science 2018 01;359(6372):191-199

School of Medicine, University of California San Diego (UCSD), 9500 Gilman Drive, La Jolla, CA 92093, USA.

Chemogenetic characterization through in vitro evolution combined with whole-genome analysis can identify antimalarial drug targets and drug-resistance genes. We performed a genome analysis of 262 parasites resistant to 37 diverse compounds. We found 159 gene amplifications and 148 nonsynonymous changes in 83 genes associated with drug-resistance acquisition, where gene amplifications contributed to one-third of resistance acquisition events. Beyond confirming previously identified multidrug-resistance mechanisms, we discovered hitherto unrecognized drug target-inhibitor pairs, including thymidylate synthase and a benzoquinazolinone, farnesyltransferase and a pyrimidinedione, and a dipeptidylpeptidase and an arylurea. This exploration of the resistome and druggable genome will likely guide drug discovery and structural biology efforts, while also advancing our understanding of resistance mechanisms available to the malaria parasite.

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aan4472DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925756PMC
January 2018
53 Reads

Publication Analysis

Top Keywords

vitro evolution
8
malaria parasite
8
druggable genome
8
gene amplifications
8
drug target-inhibitor
4
confirming identified
4
events confirming
4
acquisition events
4
identified multidrug-resistance
4
mechanisms discovered
4
unrecognized drug
4
hitherto unrecognized
4
discovered hitherto
4
resistance acquisition
4
multidrug-resistance mechanisms
4
amplifications contributed
4
nonsynonymous changes
4
148 nonsynonymous
4
amplifications 148
4
159 gene
4

References

(Supplied by CrossRef)

Similar Publications